Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Fröhlich

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Cardiology|October 4, 2022
The Obesity Paradox in Heart Failure: Is It Still Valid in Light of New Therapies?Hanna Fröhlich, Norbert Frey, Lutz Frankenstein, et al.
Revista Espanola De Cardiologia (English Ed.)|September 28, 2015
Multidisciplinary Approach for Patients Hospitalized With Heart FailureLutz Frankenstein, Hanna Fröhlich, John G F Cleland
European Heart Journal. Quality of Care & Clinical Outcomes|June 2, 2026
Affordability of Innovation -Cost-effectiveness and Budget Impact Analysis of Acoramidis in Transthyretin Amyloid Cardiomyopathy in the German Health-care SystemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 5, 2023
Prognostic relevance of gradual weight changes on long-term mortality in chronic heart failureTobias Täger, Jennifer Franke, Norbert Frey, et al.
Pharmacoeconomics|June 2, 2026
Cost-Effectiveness and Budget-Impact Analysis of Semaglutide in Heart Failure with Preserved Ejection Fraction and Obesity in the German Health-Care SystemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 25, 2025
Cost-effectiveness and budget-impact analysis of Acetazolamide in decompensated heart failure patients with volume overload in the German health care systemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
Heart Failure Reviews|March 16, 2019
READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trialsTobias Täger, Hanna Fröhlich, Mirjam Seiz, et al.
International Journal of Cardiology|May 19, 2026
Cost-effectiveness and budget-impact analysis of tirzepatide in heart failure with preserved ejection fraction and obesity in the German health-care systemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 6, 2017
Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failureTobias Täger, Clara Wiebalck, Hanna Fröhlich, et al.
ESC Heart Failure|July 2, 2019
N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failureJohannes Schnorbach, Hanna Fröhlich, Tobias Täger, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cardiology|October 4, 2022
The Obesity Paradox in Heart Failure: Is It Still Valid in Light of New Therapies?Hanna Fröhlich, Norbert Frey, Lutz Frankenstein, et al.
Revista Espanola De Cardiologia (English Ed.)|September 28, 2015
Multidisciplinary Approach for Patients Hospitalized With Heart FailureLutz Frankenstein, Hanna Fröhlich, John G F Cleland
European Heart Journal. Quality of Care & Clinical Outcomes|June 2, 2026
Affordability of Innovation -Cost-effectiveness and Budget Impact Analysis of Acoramidis in Transthyretin Amyloid Cardiomyopathy in the German Health-care SystemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 5, 2023
Prognostic relevance of gradual weight changes on long-term mortality in chronic heart failureTobias Täger, Jennifer Franke, Norbert Frey, et al.
Pharmacoeconomics|June 2, 2026
Cost-Effectiveness and Budget-Impact Analysis of Semaglutide in Heart Failure with Preserved Ejection Fraction and Obesity in the German Health-Care SystemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 25, 2025
Cost-effectiveness and budget-impact analysis of Acetazolamide in decompensated heart failure patients with volume overload in the German health care systemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
Heart Failure Reviews|March 16, 2019
READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trialsTobias Täger, Hanna Fröhlich, Mirjam Seiz, et al.
International Journal of Cardiology|May 19, 2026
Cost-effectiveness and budget-impact analysis of tirzepatide in heart failure with preserved ejection fraction and obesity in the German health-care systemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 6, 2017
Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failureTobias Täger, Clara Wiebalck, Hanna Fröhlich, et al.
ESC Heart Failure|July 2, 2019
N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failureJohannes Schnorbach, Hanna Fröhlich, Tobias Täger, et al.
Pageof 4